Harvard Bioscience, Inc. (HBIO)
| Market Cap | 235.07M |
| Revenue (ttm) | 116.83M |
| Net Income (ttm) | -1.86M |
| Shares Out | 40.81M |
| EPS (ttm) | -0.05 |
| PE Ratio | n/a |
| Forward PE | 19.46 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 242,311 |
| Open | 5.50 |
| Previous Close | 5.53 |
| Day's Range | 5.48 - 5.84 |
| 52-Week Range | 3.87 - 8.75 |
| Beta | 1.76 |
| Analysts | Strong Buy |
| Price Target | 10.00 (+73.6%) |
| Earnings Date | n/a |
About HBIO
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development. It offers physiology, cell, and molecular instruments, such as syringe and peristaltic pump products, as well as a range of instruments and accessories for tissue and organ based lab research, including surgical products, infusion systems, and behavior research systems; and spectrophotometers, microplate readers, amino acid analyzers, gel electrophoresis equi...
Financial Performance
Financial StatementsAnalyst Forecast
According to 3 analysts, the average rating for HBIO stock is "Strong Buy." The 12-month stock price forecast is 10.00, which is an increase of 73.61% from the latest price.
News
Harvard Bioscience (HBIO) Q3 Earnings Meet Estimates
Harvard Bioscience (HBIO) delivered earnings and revenue surprises of 0.00% and 5.56%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Harvard Bioscience Announces Third Quarter 2021 Financial Results
Strong double digit revenue growth, solid margin performance despite global supply chain disruptions
Harvard Bioscience (HBIO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Harvard Bioscience (HBIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Harvard Bioscience Schedules Third Quarter 2021 Earnings Conference Call for November 3, 2021 at 8:00 AM ET
HOLLISTON, Mass., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for third quarter ended September 30, 2021, before the market opens on Nov...
Harvard Bioscience (HBIO) Tops Q2 Earnings and Revenue Estimates
Harvard Bioscience (HBIO) delivered earnings and revenue surprises of 20.00% and 6.56%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Harvard Bioscience Announces Second Quarter 2021 Financial Results
Strong double digit revenue growth, solid margin performance despite global supply chain disruptions
Harvard Bioscience (HBIO) Reports Next Week: What to Know Ahead of the Release
Harvard Bioscience (HBIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Harvard Bioscience Schedules Second Quarter 2021 Earnings Conference Call for August 5, 2021 at 8:00 AM ET
HOLLISTON, Mass., July 19, 2021 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for second quarter ended June 30, 2021 before the market opens on August 5...
Are You Looking for a Top Momentum Pick? Why Harvard Bioscience (HBIO) is a Great Choice
Does Harvard Bioscience (HBIO) have what it takes to be a top stock pick for momentum investors? Let's find out.
Harvard Bioscience (HBIO) Is a Great Choice for "Trend" Investors, Here's Why
Harvard Bioscience (HBIO) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed throu...
4 Breakout Stocks You Must Add Right Away to Your Portfolio
The logic behind this strategy for stock selection is to identify stocks that are trading within a narrow band.
5 Stocks with Solid Track Records at Attractive Prices
This is probably the time to focus on fundamentals because we don't want to overpay for stocks in a buoyant market.
Surging Earnings Estimates Signal Upside for Harvard Bioscience (HBIO) Stock
Harvard Bioscience (HBIO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Harvard Bioscience (HBIO) Soars 8.3%: Is Further Upside Left in the Stock?
Harvard Bioscience (HBIO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength dow...
Harvard Bioscience (HBIO) Tops Q1 Earnings and Revenue Estimates
Harvard Bioscience (HBIO) delivered earnings and revenue surprises of 66.67% and 6.68%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Harvard Bioscience Announces First Quarter 2021 Financial Results
Sales effectiveness, pre-clinical product demand and disciplined cost management result in improved revenues and margins
Harvard Bioscience Schedules First Quarter 2021 Earnings Conference Call for May 6, 2021 at 8:00 AM ET
HOLLISTON, Mass., April 19, 2021 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for first quarter ended March 31, 2021 before the market opens on May 6, ...
Harvard Bioscience: Q4 Earnings Insights
Shares of Harvard Bioscience (NASDAQ:HBIO) remained unaffected after the company reported Q4 results. Quarterly Results Earnings per share increased 0.00% year over year to $0.08, which beat the estimat...
Preview: Harvard Bioscience's Earnings
On Wednesday, March 10, Harvard Bioscience (NASDAQ:HBIO) will release its latest earnings report. Decipher the announcement with Benzinga's help.
Harvard Bioscience Schedules Fourth Quarter 2020 Earnings Conference Call for March 10, 2021 at 8:00 AM ET
HOLLISTON, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for fourth quarter ended December 31, 2020 before the market opens on Marc...
Harvard Bioscience Announces New Credit Facility
HOLLISTON, Mass., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (“Harvard Bioscience”) today announced the refinancing of its debt with the closing of a new $65 million credi...
Harvard Bioscience to attend Benchmark's 9th Annual Discovery One-on-One Conference
HOLLISTON, Mass., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), today announced that Jim Green, Chairman, President and CEO, and Michael Rossi, CFO will participate in The B...
Harvard Bioscience Schedules Third Quarter 2020 Earnings Conference Call for November 5, 2020 at 8:00 AM ET
HOLLISTON, MA., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for third quarter ended September 30, 2020 before the market opens on Novemb...
Harvard Bioscience to Present at Singular Research Compelling Values Webinar
HOLLISTON, Mass., Sept. 16, 2020 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, President and CEO, will present at the Singular Research Compelling Values ...